Infliximab versus azathioprine to prevent postoperative recurrence in Crohn's disease: are all controversial issues defined?
Colorectal Surgery Unit, Cajuru University Hospital, Catholic University of Parana, Curitiba, PR, Brazil. Electronic address: pgkotze@hotmail.com.
Paulo Gustavo
PG
Kotze
Takayuki
T
Yamamoto
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D003424:Crohn Disease / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000069285:Infliximab; D008297:Male
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D000069285:Infliximab; D001379:Azathioprine